Error: Could not add to watchlist. X
+ Watchlist

Urigen Pharmaceuticals Inc

1237143D:US
NASDAQ CM
Pending Listing
1237143D:US is pending listing
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Urigen Pharmaceuticals Inc operates as a pharmaceutical company that develops products for patients with urological ailments, including the amelioration of Painful Bladder Syndrome, Urethritis, Nocturia and Over Active Bladder.
Address
675 Highway One B-206
New Brunswick, NJ 08902
United States
Phone
1-732-640-0160